[ad_1] The arthritis drug tocilizumab has shown promise in preventing extreme inflammation in seriously ill COVID-19 patients, according to a French clinical study. The treatment, which suppresses the body’s natural immune response, was found to “significantly” reduce the number of deaths or life-support interventions compared to a control group of …
Read More »Bangalore: shortage of hydroxychloroquine, an arthritis pain, lupus patients | Bengaluru News
[ad_1] BENGALURU: Due to its use as prophylaxis for Covid-19, the antimalarial drug hydroxychloroquine (HCQ) is not available to those who regularly consume it: arthritis and lupus patients. The massive government purchase of HCQ directly from manufacturers has led to a shortage of medications for patients with rheumatoid arthritis, general …
Read More »